CYP19A1 and cancer: Studies focused on endometrial carcinoma have revealed a paracrine signaling axis whereby cancer cells produce IL-6 to stimulate stromal cells to upregulate aromatase and produce estrogen, thus inducing a cycle of increased cancer cell proliferation and IL-6 production [71].